Adoptive Immunotherapy with T Lymphocytes Engineered for Enhanced Survival
by
nih.govPosted
Tue 03 Aug 2010 5:00pm
Description of Invention:
Available for licensing is a composition, comprising genetically engineered lymphocytes, transduced to express elevated levels of cytokine proteins. This technology is useful for improving cellular adoptive immunotherapies to treat a range of infectious diseases and cancers.
Adoptive immunothera ...
Read on »
Natural Therapies for Chronic Lymphocytic Leukemia
by
Melissa G.Posted
Tue 11 Sep 2012 8:34am
As a lymphatic drainage therapist, I work with many cancer patients in varying phases of their cancer recovery.
It seems like we've been seeing more Chronic Lymphocytic Leukemia (CLL) recently and I thought it would be a good idea to provide some recommendation for natural treatments and natural therapies for these individuals to consider in ...
Read on »
Collagenous Colitis and Lymphocytic Colitis
by
Dr. Anshu GuptaPosted
Tue 02 Jun 2009 4:40pm
What are collagenous colitis and lymphocytic colitis?
Inflammatory bowel disease is the general name for diseases that cause inflammation in the intestines, most often referring to Crohn’s disease and ulcerative colitis. Collagenous colitis and lymphocytic colitis are two other types of bowel inflammation that affect the colon. The c ...
Read on »
Collagenous Colitis and Lymphocytic Colitis
by
Dr. Anshu GuptaPosted
Tue 02 Jun 2009 4:39pm
What are collagenous colitis and lymphocytic colitis?
Inflammatory bowel disease is the general name for diseases that cause inflammation in the intestines, most often referring to Crohn’s disease and ulcerative colitis. Collagenous colitis and lymphocytic colitis are two other types of bowel inflammation that affect the colon. The c ...
Read on »
B-cell Surface Reactive Antibodies for the Treatment of B-Cell Chronic Lymphocytic Leukemia
by
nih.govPosted
Sun 11 Oct 2009 5:00pm
Description of Invention:
B-cell chronic lymphocytic leukemia (B-CLL) is a cancer characterized by a progressive accumulation of functionally incompetent lymphocytes. Despite high morbidity and mortality, the only available potential cure is allogeneic hematopoietic stem cell transplantation (alloHSCST). However, there is le ...
Read on »
Mucosal Cytotoxic T Lymphocyte Responses
by
nih.govPosted
Mon 30 Aug 2010 5:00pm
Description of Invention:
The invention offered for licensing provides methods and compositions for induction of an antigen-specific, mucosal cytotoxic T lymphocyte (CTL) response useful in preventing and treating infections with pathogens that gain entry via a mucosal surface. The methods of the invention involve administerin ...
Read on »
Aarkstore Enterprise Chronic Lymphocytic Leukemia (CLL) Global Clinical Trial Review, Q4, 2010
by
AarkstorePosted
Tue 18 Jan 2011 7:29am
Aarkstore announce a new report "Chronic Lymphocytic Leukemia (CLL) Global Clinical Trial Review, Q4, 2010 " through its vast collection of market research report.
Summary
“Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, Q4, 2010 provides data on the Chronic Lymphocytic Leukemia (CLL) clinical trial scenario. This re ...
Read on »